久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/23 | 3,790 | 3,799 | 3,762 | 3,780 | +6 | +0.2% | 101,800 |
2024/04/22 | 3,732 | 3,781 | 3,720 | 3,774 | +55 | +1.5% | 172,700 |
2024/04/19 | 3,738 | 3,753 | 3,695 | 3,719 | -19 | -0.5% | 170,500 |
2024/04/18 | 3,745 | 3,791 | 3,714 | 3,738 | +13 | +0.3% | 196,300 |
2024/04/17 | 3,800 | 3,800 | 3,708 | 3,725 | -75 | -2% | 164,500 |
2024/04/16 | 3,794 | 3,819 | 3,766 | 3,800 | -25 | -0.7% | 200,300 |
2024/04/15 | 3,909 | 3,930 | 3,784 | 3,825 | -84 | -2.1% | 304,500 |
2024/04/12 | 3,868 | 3,927 | 3,792 | 3,909 | -29 | -0.7% | 311,400 |
2024/04/11 | 3,932 | 3,969 | 3,901 | 3,938 | -17 | -0.4% | 162,300 |
2024/04/10 | 3,984 | 4,002 | 3,953 | 3,955 | -5 | -0.1% | 128,400 |
2024/04/09 | 3,957 | 3,962 | 3,921 | 3,960 | +3 | +0.1% | 135,200 |
2024/04/08 | 3,950 | 3,968 | 3,915 | 3,957 | +31 | +0.8% | 102,200 |
2024/04/05 | 3,859 | 3,926 | 3,840 | 3,926 | +44 | +1.1% | 150,200 |
2024/04/04 | 3,875 | 3,902 | 3,845 | 3,882 | +25 | +0.6% | 123,000 |
2024/04/03 | 3,830 | 3,879 | 3,817 | 3,857 | +16 | +0.4% | 139,900 |
2024/04/02 | 3,901 | 3,913 | 3,830 | 3,841 | -74 | -1.9% | 145,100 |
2024/04/01 | 3,962 | 3,971 | 3,903 | 3,915 | -58 | -1.5% | 175,300 |
2024/03/29 | 3,910 | 3,977 | 3,897 | 3,973 | +60 | +1.5% | 151,500 |
2024/03/28 | 3,990 | 4,002 | 3,897 | 3,913 | -87 | -2.2% | 155,400 |
2024/03/27 | 4,031 | 4,038 | 3,995 | 4,000 | -5 | -0.1% | 118,800 |
2024/03/26 | 3,976 | 4,010 | 3,933 | 4,005 | +20 | +0.5% | 135,800 |
2024/03/25 | 4,020 | 4,054 | 3,985 | 3,985 | -50 | -1.2% | 145,400 |
2024/03/22 | 4,003 | 4,037 | 3,971 | 4,035 | +41 | +1% | 130,200 |
2024/03/21 | 4,032 | 4,032 | 3,990 | 3,994 | -11 | -0.3% | 162,100 |
2024/03/19 | 3,976 | 4,008 | 3,962 | 4,005 | +16 | +0.4% | 201,100 |
2024/03/18 | 3,958 | 4,014 | 3,930 | 3,989 | +88 | +2.3% | 338,200 |
2024/03/15 | 3,820 | 3,902 | 3,808 | 3,901 | +73 | +1.9% | 605,600 |
2024/03/14 | 3,817 | 3,828 | 3,792 | 3,828 | +28 | +0.7% | 187,300 |
2024/03/13 | 3,807 | 3,841 | 3,788 | 3,800 | -19 | -0.5% | 189,700 |
2024/03/12 | 3,816 | 3,839 | 3,771 | 3,819 | -2 | -0.1% | 140,200 |
2024/03/11 | 3,833 | 3,839 | 3,777 | 3,821 | -21 | -0.5% | 206,700 |
2024/03/08 | 3,803 | 3,856 | 3,774 | 3,842 | +37 | +1% | 223,300 |
2024/03/07 | 3,805 | 3,824 | 3,779 | 3,805 | +4 | +0.1% | 159,400 |
2024/03/06 | 3,781 | 3,841 | 3,780 | 3,801 | +21 | +0.6% | 134,600 |
2024/03/05 | 3,813 | 3,826 | 3,762 | 3,780 | -62 | -1.6% | 175,500 |
2024/03/04 | 3,870 | 3,884 | 3,833 | 3,842 | -31 | -0.8% | 171,900 |
2024/03/01 | 3,874 | 3,913 | 3,862 | 3,873 | -1 | ±0% | 167,900 |
2024/02/29 | 3,901 | 3,915 | 3,850 | 3,874 | -44 | -1.1% | 201,200 |
2024/02/28 | 3,943 | 3,944 | 3,891 | 3,918 | -79 | -2% | 178,500 |
2024/02/27 | 4,025 | 4,037 | 3,978 | 3,997 | -31 | -0.8% | 233,000 |
2024/02/26 | 3,994 | 4,050 | 3,970 | 4,028 | +55 | +1.4% | 238,900 |
2024/02/22 | 4,000 | 4,014 | 3,958 | 3,973 | -32 | -0.8% | 203,300 |
2024/02/21 | 4,042 | 4,042 | 3,981 | 4,005 | -25 | -0.6% | 130,600 |
2024/02/20 | 4,036 | 4,055 | 4,020 | 4,030 | ±0 | ±0% | 119,400 |
2024/02/19 | 4,036 | 4,052 | 3,998 | 4,030 | -28 | -0.7% | 145,100 |
2024/02/16 | 4,024 | 4,076 | 3,997 | 4,058 | +84 | +2.1% | 229,400 |
2024/02/15 | 4,097 | 4,097 | 3,958 | 3,974 | -111 | -2.7% | 243,400 |
2024/02/14 | 4,130 | 4,132 | 4,040 | 4,085 | -67 | -1.6% | 179,900 |
2024/02/13 | 4,150 | 4,162 | 4,098 | 4,152 | +9 | +0.2% | 178,600 |
2024/02/09 | 4,106 | 4,162 | 4,085 | 4,143 | +7 | +0.2% | 158,900 |
251~
300
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム